Skip to content
  • Switzerland
  • Group A

Novartis

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need.

  • United States
  • Group A

CooperVision

CooperVision produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics.

  • United States
  • Group A

Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases.

  • Germany
  • Group A

Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.

  • Switzerland
  • Group A

Roche in Ophthalmology

Through innovation in the scientific discovery of new potential drug targets, personalised healthcare, molecular engineering, biomarkers and continuous drug delivery, Roche strives to design the right therapies for the right patients.

  • Japan
  • Group A

Santen

Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries.